Bluebird Bio readies Zynteglo launch as EU approves 'refined' manufacturing

23rd October 2019 Uncategorised 0

A manufacturing hiccup that Bluebird Bio’s believed might delay its gene therapy launch until 2020 has not only been overcome, the company now says it expects to enroll its first patients there yet this year.

More: Bluebird Bio readies Zynteglo launch as EU approves 'refined' manufacturing
Source: fierce